View Financial HealthProteak Uno. de 配当と自社株買い配当金 基準チェック /06Proteak Uno. de配当金を支払った記録がありません。主要情報n/a配当利回り-0.6%バイバック利回り総株主利回り-0.6%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesReported Earnings • Mar 05Full year 2025 earnings released: Mex$0.41 loss per share (vs Mex$1.85 loss in FY 2024)Full year 2025 results: Mex$0.41 loss per share (improved from Mex$1.85 loss in FY 2024). Revenue: Mex$710.4m (down 38% from FY 2024). Net loss: Mex$441.1m (loss narrowed 30% from FY 2024).お知らせ • Mar 03Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico MexicoBuy Or Sell Opportunity • Jan 02Now 61% overvaluedOver the last 90 days, the stock has fallen 65% to Mex$0.091. The fair value is estimated to be Mex$0.056, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company became loss making.New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (Mex$80.5m market cap, or US$4.47m). Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).分析記事 • Dec 17Is Proteak Uno. de (BMV:TEAKCPO) Using Debt Sensibly?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Oct 30Third quarter 2025 earnings released: Mex$0.20 loss per share (vs Mex$0.74 loss in 3Q 2024)Third quarter 2025 results: Mex$0.20 loss per share (improved from Mex$0.74 loss in 3Q 2024). Revenue: Mex$158.2m (down 47% from 3Q 2024). Net loss: Mex$74.2m (loss narrowed 73% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.Reported Earnings • Jul 29Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: Mex$34.0m (down 89% from 2Q 2024). Net loss: Mex$40.3m (loss narrowed 83% from 2Q 2024).Reported Earnings • May 04First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: Mex$316.1m (down 11% from 1Q 2024). Net loss: Mex$168.9m (loss widened 192% from 1Q 2024).Buy Or Sell Opportunity • Apr 21Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 36% to Mex$0.35. The fair value is estimated to be Mex$0.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Apr 15Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico Mexico分析記事 • Apr 09Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Popularity With Investors Under Threat As Stock Sinks 27%Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders won't be pleased to see that the share price has had a very...分析記事 • Apr 07Estimating The Intrinsic Value Of Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO)Key Insights The projected fair value for Proteak Uno. de is Mex$0.44 based on 2 Stage Free Cash Flow to Equity Current...Buy Or Sell Opportunity • Apr 02Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 89% to Mex$0.53. The fair value is estimated to be Mex$0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Mex$192.5m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (Mex$192.5m market cap, or US$9.66m).Buy Or Sell Opportunity • Mar 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 93% to Mex$0.60. The fair value is estimated to be Mex$0.50, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Mar 02Full year 2024 earnings released: Mex$1.85 loss per share (vs Mex$0.82 loss in FY 2023)Full year 2024 results: Mex$1.85 loss per share (further deteriorated from Mex$0.82 loss in FY 2023). Revenue: Mex$1.19b (down 15% from FY 2023). Net loss: Mex$682.2m (loss widened 144% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance.分析記事 • Feb 22Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) 44% Price Boost Is Out Of Tune With RevenuesDespite an already strong run, Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shares have been powering on, with a gain of...分析記事 • Jan 08Is Proteak Uno. de (BMV:TEAKCPO) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Jan 08Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) 52% Share Price Surge Not Quite Adding UpProteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders are no doubt pleased to see that the share price has bounced...Board Change • Jan 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Director Ricardo Haua was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 02Third quarter 2024 earnings released: Mex$0.80 loss per share (vs Mex$0.33 loss in 3Q 2023)Third quarter 2024 results: Mex$0.80 loss per share (further deteriorated from Mex$0.33 loss in 3Q 2023). Revenue: Mex$295.8m (down 12% from 3Q 2023). Net loss: Mex$294.8m (loss widened 140% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 32 percentage points per year, which is a significant difference in performance.分析記事 • Oct 13More Unpleasant Surprises Could Be In Store For Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Shares After Tumbling 42%Unfortunately for some shareholders, the Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) share price has dived 42% in the...New Risk • Sep 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Mex$193.9m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (Mex$193.9m market cap, or US$9.91m).New Risk • Aug 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Market cap is less than US$100m (Mex$321.4m market cap, or US$16.2m).分析記事 • Aug 28Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO) May Have Run Too Fast Too Soon With Recent 26% Price PlummetUnfortunately for some shareholders, the Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) share price has dived 26% in the...Reported Earnings • Jul 27Second quarter 2024 earnings released: Mex$0.73 loss per share (vs Mex$0.03 loss in 2Q 2023)Second quarter 2024 results: Mex$0.73 loss per share (further deteriorated from Mex$0.03 loss in 2Q 2023). Revenue: Mex$295.4m (down 22% from 2Q 2023). Net loss: Mex$268.6m (loss widened Mex$256.0m from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.New Risk • May 01New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -Mex$56m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 6.0% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-Mex$56m). Market cap is less than US$100m (Mex$467.9m market cap, or US$27.5m).Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: Mex$355.2m (down 14% from 1Q 2023). Net loss: Mex$61.7m (down 454% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.分析記事 • Mar 02Does Proteak Uno. de (BMV:TEAKCPO) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Mar 02Positive Sentiment Still Eludes Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO) Following 26% Share Price SlumpTo the annoyance of some shareholders, Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shares are down a considerable 26...New Risk • Feb 29New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.7% average weekly change). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Mex$599.0m market cap, or US$35.1m).Reported Earnings • Feb 29Full year 2023 earnings released: Mex$0.94 loss per share (vs Mex$0.82 loss in FY 2022)Full year 2023 results: Mex$0.94 loss per share (further deteriorated from Mex$0.82 loss in FY 2022). Revenue: Mex$1.41b (down 27% from FY 2022). Net loss: Mex$351.1m (loss widened 15% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.Reported Earnings • Oct 31Third quarter 2023 earnings released: Mex$0.11 loss per share (vs Mex$0.03 loss in 3Q 2022)Third quarter 2023 results: Mex$0.11 loss per share (further deteriorated from Mex$0.03 loss in 3Q 2022). Revenue: Mex$335.5m (down 27% from 3Q 2022). Net loss: Mex$123.0m (loss widened Mex$110.1m from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.分析記事 • Sep 21Is Proteak Uno. de (BMV:TEAKCPO) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Reported Earnings • Jul 31Second quarter 2023 earnings released: Mex$0.01 loss per share (vs Mex$0.09 loss in 2Q 2022)Second quarter 2023 results: Mex$0.01 loss per share (improved from Mex$0.09 loss in 2Q 2022). Revenue: Mex$379.0m (down 23% from 2Q 2022). Net loss: Mex$12.6m (loss narrowed 54% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.New Risk • Jul 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 35% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (9.8% net profit margin). Market cap is less than US$100m (Mex$1.13b market cap, or US$66.1m).Reported Earnings • Mar 02Full year 2022 earnings released: EPS: Mex$0.56 (vs Mex$0.69 in FY 2021)Full year 2022 results: EPS: Mex$0.56 (down from Mex$0.69 in FY 2021). Revenue: Mex$1.96b (up 1.0% from FY 2021). Net income: Mex$208.4m (down 5.4% from FY 2021). Profit margin: 11% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 29Third quarter 2022 earnings released: Mex$0.039 loss per share (vs Mex$0.14 profit in 3Q 2021)Third quarter 2022 results: Mex$0.039 loss per share (down from Mex$0.14 profit in 3Q 2021). Revenue: Mex$441.8m (down 25% from 3Q 2021). Net loss: Mex$14.7m (down 133% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: Mex$0.16 (vs Mex$0.60 in 2Q 2021)Second quarter 2022 results: EPS: Mex$0.16 (down from Mex$0.60 in 2Q 2021). Revenue: Mex$490.2m (down 7.6% from 2Q 2021). Net loss: Mex$27.2m (down 114% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.分析記事 • Jul 01The Market Doesn't Like What It Sees From Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Earnings Yet As Shares Tumble 29%Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders that were waiting for something to happen have been dealt a...Valuation Update With 7 Day Price Move • Jun 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to Mex$3.51, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 4x in the Forestry industry in South America. Total loss to shareholders of 62% over the past three years.分析記事 • Jun 09Proteak Uno. de (BMV:TEAKCPO) Has A Somewhat Strained Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Jun 08Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to Mex$4.00, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Forestry industry in South America. Total loss to shareholders of 60% over the past three years.Reported Earnings • May 05First quarter 2022 earnings released: EPS: Mex$0.19 (vs Mex$0.19 loss in 1Q 2021)First quarter 2022 results: EPS: Mex$0.19 (up from Mex$0.19 loss in 1Q 2021). Revenue: Mex$640.5m (up 38% from 1Q 2021). Net income: Mex$183.9m (up Mex$245.3m from 1Q 2021). Profit margin: 29% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.分析記事 • Apr 01There's Been No Shortage Of Growth Recently For Proteak Uno. de's (BMV:TEAKCPO) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: Mex$0.66 (up from Mex$0.64 loss in FY 2020). Revenue: Mex$1.98b (up 70% from FY 2020). Net income: Mex$247.6m (up Mex$452.9m from FY 2020). Profit margin: 13% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.分析記事 • Feb 02Proteak Uno. de (BMV:TEAKCPO) Takes On Some Risk With Its Use Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Board Change • Dec 05Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 5 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.分析記事 • Oct 14Is Proteak Uno. de (BMV:TEAKCPO) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to Mex$5.96, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 8x in the Forestry industry in South America. Total loss to shareholders of 49% over the past three years.Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS Mex$0.56 (vs Mex$0.003 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Mex$493.7m (up 96% from 2Q 2020). Net income: Mex$210.9m (up Mex$211.8m from 2Q 2020). Profit margin: 43% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.分析記事 • May 08Proteak Uno. de's (BMV:TEAKCPO) Solid Profits Have Weak FundamentalsProteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) announced strong profits, but the stock was stagnant. We did some digging...分析記事 • Mar 27Proteak Uno. de (BMV:TEAKCPO) Has Debt But No Earnings; Should You Worry?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Mar 04Full year 2020 earnings released: Mex$0.74 loss per share (vs Mex$0.21 loss in FY 2019)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: Mex$1.36b (up 1.6% from FY 2019). Net loss: Mex$236.1m (loss widened 250% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings.Is New 90 Day High Low • Feb 24New 90-day high: Mex$5.44The company is up 9.0% from its price of Mex$5.00 on 24 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Forestry industry, which is up 36% over the same period.分析記事 • Feb 02Proteak Uno. de (BMV:TEAKCPO) Share Prices Have Dropped 80% In The Last Five YearsWe're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...Is New 90 Day High Low • Jan 28New 90-day low: Mex$3.80The company is down 3.0% from its price of Mex$3.90 on 30 October 2020. The Mexican market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 21% over the same period.分析記事 • Dec 10Is Proteak Uno. de (BMV:TEAKCPO) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is New 90 Day High Low • Nov 07New 90-day high: Mex$4.02The company is up 15% from its price of Mex$3.51 on 07 August 2020. The Mexican market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 8.0% over the same period.決済の安定と成長配当データの取得安定した配当: TEAK CPOの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: TEAK CPOの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Proteak Uno. de 配当利回り対市場TEAK CPO 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (TEAK CPO)n/a市場下位25% (MX)2.2%市場トップ25% (MX)5.6%業界平均 (Forestry)3.0%アナリスト予想 (TEAK CPO) (最長3年)n/a注目すべき配当: TEAK CPOは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: TEAK CPOは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: TEAK CPOの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: TEAK CPOが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YMX 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/29 19:45終値2026/05/28 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Proteak Uno, S.A.B. de C.V. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Mar 05Full year 2025 earnings released: Mex$0.41 loss per share (vs Mex$1.85 loss in FY 2024)Full year 2025 results: Mex$0.41 loss per share (improved from Mex$1.85 loss in FY 2024). Revenue: Mex$710.4m (down 38% from FY 2024). Net loss: Mex$441.1m (loss narrowed 30% from FY 2024).
お知らせ • Mar 03Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico Mexico
Buy Or Sell Opportunity • Jan 02Now 61% overvaluedOver the last 90 days, the stock has fallen 65% to Mex$0.091. The fair value is estimated to be Mex$0.056, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (Mex$80.5m market cap, or US$4.47m). Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change).
分析記事 • Dec 17Is Proteak Uno. de (BMV:TEAKCPO) Using Debt Sensibly?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Oct 30Third quarter 2025 earnings released: Mex$0.20 loss per share (vs Mex$0.74 loss in 3Q 2024)Third quarter 2025 results: Mex$0.20 loss per share (improved from Mex$0.74 loss in 3Q 2024). Revenue: Mex$158.2m (down 47% from 3Q 2024). Net loss: Mex$74.2m (loss narrowed 73% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Jul 29Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: Mex$34.0m (down 89% from 2Q 2024). Net loss: Mex$40.3m (loss narrowed 83% from 2Q 2024).
Reported Earnings • May 04First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: Mex$316.1m (down 11% from 1Q 2024). Net loss: Mex$168.9m (loss widened 192% from 1Q 2024).
Buy Or Sell Opportunity • Apr 21Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 36% to Mex$0.35. The fair value is estimated to be Mex$0.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Apr 15Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico Mexico
分析記事 • Apr 09Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Popularity With Investors Under Threat As Stock Sinks 27%Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders won't be pleased to see that the share price has had a very...
分析記事 • Apr 07Estimating The Intrinsic Value Of Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO)Key Insights The projected fair value for Proteak Uno. de is Mex$0.44 based on 2 Stage Free Cash Flow to Equity Current...
Buy Or Sell Opportunity • Apr 02Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 89% to Mex$0.53. The fair value is estimated to be Mex$0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Mex$192.5m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (Mex$192.5m market cap, or US$9.66m).
Buy Or Sell Opportunity • Mar 10Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 93% to Mex$0.60. The fair value is estimated to be Mex$0.50, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Mar 02Full year 2024 earnings released: Mex$1.85 loss per share (vs Mex$0.82 loss in FY 2023)Full year 2024 results: Mex$1.85 loss per share (further deteriorated from Mex$0.82 loss in FY 2023). Revenue: Mex$1.19b (down 15% from FY 2023). Net loss: Mex$682.2m (loss widened 144% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance.
分析記事 • Feb 22Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) 44% Price Boost Is Out Of Tune With RevenuesDespite an already strong run, Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shares have been powering on, with a gain of...
分析記事 • Jan 08Is Proteak Uno. de (BMV:TEAKCPO) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Jan 08Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) 52% Share Price Surge Not Quite Adding UpProteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders are no doubt pleased to see that the share price has bounced...
Board Change • Jan 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Director Ricardo Haua was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 02Third quarter 2024 earnings released: Mex$0.80 loss per share (vs Mex$0.33 loss in 3Q 2023)Third quarter 2024 results: Mex$0.80 loss per share (further deteriorated from Mex$0.33 loss in 3Q 2023). Revenue: Mex$295.8m (down 12% from 3Q 2023). Net loss: Mex$294.8m (loss widened 140% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 32 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 13More Unpleasant Surprises Could Be In Store For Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Shares After Tumbling 42%Unfortunately for some shareholders, the Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) share price has dived 42% in the...
New Risk • Sep 25New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Mex$193.9m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (Mex$193.9m market cap, or US$9.91m).
New Risk • Aug 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Market cap is less than US$100m (Mex$321.4m market cap, or US$16.2m).
分析記事 • Aug 28Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO) May Have Run Too Fast Too Soon With Recent 26% Price PlummetUnfortunately for some shareholders, the Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) share price has dived 26% in the...
Reported Earnings • Jul 27Second quarter 2024 earnings released: Mex$0.73 loss per share (vs Mex$0.03 loss in 2Q 2023)Second quarter 2024 results: Mex$0.73 loss per share (further deteriorated from Mex$0.03 loss in 2Q 2023). Revenue: Mex$295.4m (down 22% from 2Q 2023). Net loss: Mex$268.6m (loss widened Mex$256.0m from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
New Risk • May 01New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -Mex$56m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 6.0% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-Mex$56m). Market cap is less than US$100m (Mex$467.9m market cap, or US$27.5m).
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: Mex$355.2m (down 14% from 1Q 2023). Net loss: Mex$61.7m (down 454% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
分析記事 • Mar 02Does Proteak Uno. de (BMV:TEAKCPO) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Mar 02Positive Sentiment Still Eludes Proteak Uno, S.A.B. de C.V. (BMV:TEAKCPO) Following 26% Share Price SlumpTo the annoyance of some shareholders, Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shares are down a considerable 26...
New Risk • Feb 29New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.7% average weekly change). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Mex$599.0m market cap, or US$35.1m).
Reported Earnings • Feb 29Full year 2023 earnings released: Mex$0.94 loss per share (vs Mex$0.82 loss in FY 2022)Full year 2023 results: Mex$0.94 loss per share (further deteriorated from Mex$0.82 loss in FY 2022). Revenue: Mex$1.41b (down 27% from FY 2022). Net loss: Mex$351.1m (loss widened 15% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
Reported Earnings • Oct 31Third quarter 2023 earnings released: Mex$0.11 loss per share (vs Mex$0.03 loss in 3Q 2022)Third quarter 2023 results: Mex$0.11 loss per share (further deteriorated from Mex$0.03 loss in 3Q 2022). Revenue: Mex$335.5m (down 27% from 3Q 2022). Net loss: Mex$123.0m (loss widened Mex$110.1m from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
分析記事 • Sep 21Is Proteak Uno. de (BMV:TEAKCPO) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Reported Earnings • Jul 31Second quarter 2023 earnings released: Mex$0.01 loss per share (vs Mex$0.09 loss in 2Q 2022)Second quarter 2023 results: Mex$0.01 loss per share (improved from Mex$0.09 loss in 2Q 2022). Revenue: Mex$379.0m (down 23% from 2Q 2022). Net loss: Mex$12.6m (loss narrowed 54% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
New Risk • Jul 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 35% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (9.8% net profit margin). Market cap is less than US$100m (Mex$1.13b market cap, or US$66.1m).
Reported Earnings • Mar 02Full year 2022 earnings released: EPS: Mex$0.56 (vs Mex$0.69 in FY 2021)Full year 2022 results: EPS: Mex$0.56 (down from Mex$0.69 in FY 2021). Revenue: Mex$1.96b (up 1.0% from FY 2021). Net income: Mex$208.4m (down 5.4% from FY 2021). Profit margin: 11% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 29Third quarter 2022 earnings released: Mex$0.039 loss per share (vs Mex$0.14 profit in 3Q 2021)Third quarter 2022 results: Mex$0.039 loss per share (down from Mex$0.14 profit in 3Q 2021). Revenue: Mex$441.8m (down 25% from 3Q 2021). Net loss: Mex$14.7m (down 133% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Reported Earnings • Jul 29Second quarter 2022 earnings released: EPS: Mex$0.16 (vs Mex$0.60 in 2Q 2021)Second quarter 2022 results: EPS: Mex$0.16 (down from Mex$0.60 in 2Q 2021). Revenue: Mex$490.2m (down 7.6% from 2Q 2021). Net loss: Mex$27.2m (down 114% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
分析記事 • Jul 01The Market Doesn't Like What It Sees From Proteak Uno, S.A.B. de C.V.'s (BMV:TEAKCPO) Earnings Yet As Shares Tumble 29%Proteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) shareholders that were waiting for something to happen have been dealt a...
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to Mex$3.51, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 4x in the Forestry industry in South America. Total loss to shareholders of 62% over the past three years.
分析記事 • Jun 09Proteak Uno. de (BMV:TEAKCPO) Has A Somewhat Strained Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to Mex$4.00, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Forestry industry in South America. Total loss to shareholders of 60% over the past three years.
Reported Earnings • May 05First quarter 2022 earnings released: EPS: Mex$0.19 (vs Mex$0.19 loss in 1Q 2021)First quarter 2022 results: EPS: Mex$0.19 (up from Mex$0.19 loss in 1Q 2021). Revenue: Mex$640.5m (up 38% from 1Q 2021). Net income: Mex$183.9m (up Mex$245.3m from 1Q 2021). Profit margin: 29% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Apr 01There's Been No Shortage Of Growth Recently For Proteak Uno. de's (BMV:TEAKCPO) Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: Mex$0.66 (up from Mex$0.64 loss in FY 2020). Revenue: Mex$1.98b (up 70% from FY 2020). Net income: Mex$247.6m (up Mex$452.9m from FY 2020). Profit margin: 13% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
分析記事 • Feb 02Proteak Uno. de (BMV:TEAKCPO) Takes On Some Risk With Its Use Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Board Change • Dec 05Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 5 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Oct 14Is Proteak Uno. de (BMV:TEAKCPO) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to Mex$5.96, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 8x in the Forestry industry in South America. Total loss to shareholders of 49% over the past three years.
Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS Mex$0.56 (vs Mex$0.003 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Mex$493.7m (up 96% from 2Q 2020). Net income: Mex$210.9m (up Mex$211.8m from 2Q 2020). Profit margin: 43% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
分析記事 • May 08Proteak Uno. de's (BMV:TEAKCPO) Solid Profits Have Weak FundamentalsProteak Uno, S.A.B. de C.V. ( BMV:TEAKCPO ) announced strong profits, but the stock was stagnant. We did some digging...
分析記事 • Mar 27Proteak Uno. de (BMV:TEAKCPO) Has Debt But No Earnings; Should You Worry?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Mar 04Full year 2020 earnings released: Mex$0.74 loss per share (vs Mex$0.21 loss in FY 2019)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: Mex$1.36b (up 1.6% from FY 2019). Net loss: Mex$236.1m (loss widened 250% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings.
Is New 90 Day High Low • Feb 24New 90-day high: Mex$5.44The company is up 9.0% from its price of Mex$5.00 on 24 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Forestry industry, which is up 36% over the same period.
分析記事 • Feb 02Proteak Uno. de (BMV:TEAKCPO) Share Prices Have Dropped 80% In The Last Five YearsWe're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...
Is New 90 Day High Low • Jan 28New 90-day low: Mex$3.80The company is down 3.0% from its price of Mex$3.90 on 30 October 2020. The Mexican market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 21% over the same period.
分析記事 • Dec 10Is Proteak Uno. de (BMV:TEAKCPO) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Is New 90 Day High Low • Nov 07New 90-day high: Mex$4.02The company is up 15% from its price of Mex$3.51 on 07 August 2020. The Mexican market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 8.0% over the same period.